Stay updated on Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.

Latest updates to the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedPage revision updated from v3.4.1 to v3.4.2; no clinical content or study details were modified. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedPage revision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check27 days agoChange DetectedGlossary display was added to aid understanding of terms in the study record. The update history/footer were revised to show 'Last Update Submitted that Met QC Criteria', display 'No FEAR Act Data', and update the site revision to v3.4.0, replacing the previous labels.SummaryDifference0.2%

- Check41 days agoChange DetectedRevision: v3.3.4 was added to the page footer, replacing the previous v3.3.3. This is a minor update with no changes to study details or functionality.SummaryDifference0.1%

- Check63 days agoChange DetectedThe Locations section now includes recruitment sites in New Jersey and New York, with the locations updated accordingly. The HHS Vulnerability Disclosure footer link has been removed and previous location subsections were replaced in the new version.SummaryDifference0.3%

- Check92 days agoChange DetectedPublication notes were updated to state that publications are automatically filled in from PubMed and may not all be about the study. The page revision label was updated to v3.3.2; to avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with SBRT vs Alone in Metastatic HNSCC Clinical Trial page.